Pharmacokinetic analysis of novel curcumin preparation in health volunteer

Pharmacokinetic analysis of novel curcumin preparation in health volunteer - Pharmacokinetic analysis of novel curcumin preparation in health volunteer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000039083

Enrollment

Registered

2020-01-08

Start date

2019-12-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteer

Interventions

Intervention, group A Novel curcumin preparation 1 90mg/day for 1 day A washout period for 1 weeks Novel curcumin preparation 2 90mg/day for 1 day A washout period for 1 weeks Theracurmin 90mg/

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The healthy volunteers

Exclusion criteria

Exclusion criteria: 1) The person with underlying disease 2) Pregnancy and nursing 3) Cognitive impairment 4) The person who uses the supplement which influence stiff shoulder 5) The person who participates in other clinical trials at the time of this study entry 6) etc

Design outcomes

Primary

Measure	Time frame
Serum curcumin concentration AUC Cmax	—

Countries

Japan

Contacts

Public ContactYoichi Sunagawa

University of Shizuoka Division of Molecular Medicine, School of Pharmaceutical Sciences

y.sunagawa@u-shizuoka-ken.ac.jp0542645765

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026